Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-Transplant Events

GI complications in pediatric patients post-BMT

Bone Marrow Transplantation volume 36, pages 51–58 (2005)Cite this article

Summary:

This retrospective study comprehensively examined hepatic and gastrointestinal complications post-bone marrow transplant (BMT) in a heterogeneous group of 132 pediatric patients that underwent 142 transplants. Hyperbilirubinemia occurred in 28% of this population with clinically evident jaundice in 16%. Acute graft-versus-host disease (GVHD) occurred in 46% of the population, with liver involvement in 39% and intestinal involvement in 60% of those with acute GVHD. Veno-occlusive disease (VOD) occurred in 18% of the population. A greater increase in hepatic transaminases was noted in GVHD and VOD than nonspecific liver injury. Serum bilirubin may help to differentiate between VOD and hepatic GVHD. Biliary sludging occurred in 20% of patients and was associated with increased morbidity. Common post transplant gastrointestinal complications included mucositis in 90%, vomiting in 85% and abdominal pain in 71%. TPN support post transplant was required in 91%. Diarrhea occurred in 67% with the most common identified etiologies reported as GVHD (27%), viral (6%), Clostridium difficile (8%) infections and unknown (28%). Typhilitis developed in 3.5%. Melena or hematochezia occurred in 11 patients (8%). However, gastrointestinal bleeding was disproportionately represented in intensive care unit admissions (5/27) and 100 day mortality (5/21). Gastrointestinal and hepatic complications represent a major cause of morbidity and mortality in pediatric BMT recipients.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Ko CW, Gooley T, Schoch HG et al. Acute pancreatitis in marrow transplant patients: prevalence at autopsy and risk factor analysis. Bone Marrow Transplant 1997; 20: 1081–1086.

    Article  CAS  PubMed  Google Scholar 

  2. Nieto Y, Russ P, Everson G et al. Acute pancreatitis during immunosuppression with tacrolimus following an allogeneic umbilical cord blood transplantation. Bone Marrow Transplant 2000; 26: 109–111.

    Article  CAS  PubMed  Google Scholar 

  3. Akpek G, Valladares JL, Lee L et al. Pancreatic insufficiency in patients with chronic graft-versus-host disease. Bone Marrow Transplant 2001; 27: 163–166.

    Article  CAS  PubMed  Google Scholar 

  4. Or R, Mehta J, Nagler A, Craciun I . Neutropenic enterocolitis associated with autologous bone marrow transplantation. Bone Marrow Transplant 1992; 9: 383–385.

    CAS  PubMed  Google Scholar 

  5. Boggio L, Pooley R, Roth SI, Winter JN . Typhilitis complicating autologous blood stem cell transplantation for breast cancer. Bone Marrow Transplant 2000; 25: 321–326.

    Article  CAS  PubMed  Google Scholar 

  6. Bilgrami S, Feingold HM, Dorsky D et al. Incidence and outcome of Clostridium difficile infection following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 1999; 23: 1039–1042.

    Article  CAS  PubMed  Google Scholar 

  7. Yolken RH, Bishop CA, Townsend TR et al. Infectious gastroenteritis in bone-marrow-transplant recipients. N Engl J Med 1982; 306: 1009–1012.

    Article  Google Scholar 

  8. Kavan P, Sochor M, Nyc O et al. Pseudomembraneous clostridium after autologous bone marrow transplantation. Bone Marrow Transplant 1998; 21: 521–523.

    Article  CAS  PubMed  Google Scholar 

  9. Perez-Ceballos E, Vallejo C, Cano H et al. Fatal upper and lower gastrointestinal cytomegalovirus disease following autologous peripheral blood stem cell transplantation. Eur J Haematol 2001; 66: 130–132.

    Article  CAS  PubMed  Google Scholar 

  10. Kottaridis PD, Peggs K, Devereux S et al. Simultaneous occurrence of Clostridium difficile and cytomegalovirus colitis in a recipient of autologous stem cell transplantation. Haematologica 2000; 85: 1116–1117.

    CAS  PubMed  Google Scholar 

  11. Holmberg LA, Boeckh M, Hooper H et al. Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation. Blood 1999; 94: 4029–4035.

    CAS  PubMed  Google Scholar 

  12. Aljurf M, Gyer M, Alrajhi A et al. Mycobacterium tuberculosis infection in allogeneic bone marrow transplantation patients. Bone Marrow Transplant 1999; 24: 551–554.

    Article  CAS  PubMed  Google Scholar 

  13. Naik HR, Chandrasekar PH . Herpes simplex virus (HSV) colitis in a bone marrow transplant recipient. Bone Marrow Transplant 1996; 17: 285–286.

    CAS  PubMed  Google Scholar 

  14. Chakrabarti S, Collingham KE, Stevens RH et al. Isolation of viruses from stools in stem cell transplant recipients: a prospective surveillance study. Bone Marrow Transplant 2000; 25: 277–282.

    Article  CAS  PubMed  Google Scholar 

  15. Shields AF, Hackman RC, Fife KH et al. Adenovirus infections in patients undergoing bone-marrow transplantation. N Engl J Med 1985; 312: 529–533.

    Article  CAS  PubMed  Google Scholar 

  16. Somervaille TCP, Kirk S, Dogan A et al. Fulminant hepatic failure caused by adenovirus infection following bone marrow transplantation for Hodgkin's disease. Bone Marrow Transplant 1999; 24: 99–101.

    Article  CAS  PubMed  Google Scholar 

  17. Mirza N, Whimbey E, Champlin R et al. Adenovirus infections in adult bone marrow transplant (BMT) recipients. Blood 1995; 86: 218a (Abstr. 859).

    Google Scholar 

  18. Roy V, Weisdorf D . Mycobacterial infections following bone marrow transplant (BMT): a retrospective review of 20 year experience. Blood 1995; 86: 218a (Abstr. 861).

    Google Scholar 

  19. Papadopoulou A, Lloyd DR, Williams MD et al. Gastrointestinal and nutritional sequelae of bone marrow transplantation. Arch Dis Child 1996; 75: 208–213.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Reiss U, Cowan M, McMillan A, Horn B . Hepatic venoocclusive disease in blood and bone marrow transplantation in children and young adults: incidence, risk factors, and outcome in a cohort of 241 patients. J Pediatr Hematol Oncol 2002; 24: 746–750.

    Article  PubMed  Google Scholar 

  21. Lones MA, Kirov I, Said JW et al. Post-transplant lymphoproliferative disorder after autologous peripheral stem cell transplantation in a pediatric patient. Bone Marrow Transplant 2000; 26: 1021–1024.

    Article  CAS  PubMed  Google Scholar 

  22. Claviez A, Tiemann M, Wagner H-J et al. Epstein–Barr virus-associated post-transplant lymphoproliferative disease after bone marrow transplantation mimicking graft-versus-host disease. Pediatr Transplant 2000; 4: 151–155.

    Article  CAS  PubMed  Google Scholar 

  23. Brugieres L, Hartmann O, Benhamou E et al. Veno-occlusive disease of the liver following high-dose chemotherapy and autologous bone marrow transplantation in children with solid tumors: incidence, clinical course and outcome. Bone Marrow Transplant 1988; 3: 53–58.

    CAS  PubMed  Google Scholar 

  24. Bisogno G, de Kraker J, Weirich A et al. Veno-occlusive disease of the liver in children treated for Wilms tumor. Med Pediatr Oncol 1997; 29: 245–251.

    Article  CAS  PubMed  Google Scholar 

  25. Meresse V, Hartmann O, Vassal G et al. Risk factors for hepatic veno-occlusive disease after high-dose busulfan-containing regimens followed by autologous bone marrow transplantation: a study in 136 children. Bone Marrow Transplant 1992; 10: 135–141.

    CAS  PubMed  Google Scholar 

  26. Carreras E, Bertz H, Arcese W et al. Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European group for blood and marrow transplantation. Blood 1998; 92: 3599–3604.

    CAS  PubMed  Google Scholar 

  27. Locasciulli A, Testa M, Valsecchi MG et al. Morbidity and mortality due to liver disease in children undergoing allogenic bone marrow transplantation: a 10-year prospective study. Blood 1997; 90: 3799–3805.

    CAS  PubMed  Google Scholar 

  28. Ozkaynak MF, Weinberg K, Kohn D et al. Hepatic veno-occlusive disease post-bone marrow transplantation in children conditioned with busulfan and cyclophosphamide: incidence, risk factors, and clinical outcome. Bone Marrow Transplant 1991; 7: 467–474.

    CAS  PubMed  Google Scholar 

  29. Ortega JA, Donaldson SS, Ivy SP et al. Venoocclusive disease of the liver after chemotherapy with vincristine, actinomycin D, and cyclophosphamide for the treatment of rhabdomyosarcoma. Cancer 1997; 79: 2435–2439.

    Article  CAS  PubMed  Google Scholar 

  30. Frisk P, Lonnerholm G, Oberg G . Disease of the liver following bone marrow transplantation in children: incidence, clinical course and outcome in a long-term perspective. Acta Paediatr 1998; 87: 579–583.

    Article  CAS  PubMed  Google Scholar 

  31. Kullendorff CM, Bekassy AN . Hepatic veno-occlusive disease in Wilms' tumor. Eur J Pediatr Surg 1996; 6: 338–340.

    Article  CAS  PubMed  Google Scholar 

  32. Shaw PJ, Hugh-Jones K, Hobbs JR et al. Busulphan and cyclophosphamide cause little early toxicity during displacement bone marrow transplantation in fifty children. Bone Marrow Transplant 1986; 1: 193–200.

    CAS  PubMed  Google Scholar 

  33. Al Otaibi A, Barker C, Anderson R, Sigalet DL . Neutropenic enterocolitis (typhilitis) after bone marrow transplant. J Pediatr Surg 2002; 37: 770–772.

    Article  PubMed  Google Scholar 

  34. Barker CC, Butzner JD, Anderson RA et al. Incidence, survival and risk factors for the development of veno-occlusive disease in pediatric stem cell transplant recipients. Bone Marrow Transplant 2003; 32: 79–87.

    Article  CAS  PubMed  Google Scholar 

  35. Gudnason T, Belani KK, Balfour Jr HH . Ganciclovir treatment of cytomegalovirus disease in immunocompromised children. Pediatr Infect Dis J 1989; 8: 436–440.

    Article  CAS  PubMed  Google Scholar 

  36. McDonald GB, Sharma P, Matthews DE et al. Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors. Hepatology 1984; 4: 116–122.

    Article  CAS  PubMed  Google Scholar 

  37. Przepiorka D, Weisdorf D, Martin P . Concensus conference on acute GVHD grading. Bone Marrow Transplant 1995; 15: 825–828.

    CAS  PubMed  Google Scholar 

  38. Werlin SL, Casper J, Antonson D, Calabro C . Pancreatitis associated with bone marrow transplantation in children. Bone Marrow Transplant 1992; 10: 65–69.

    CAS  PubMed  Google Scholar 

  39. Essel JH, Schroeder MT, Harman GS et al. Ursodiol prophylaxis against hepatic complications of allogenic bone marrow transplantation. Ann Intern Med 1998; 128: 975–981.

    Article  Google Scholar 

  40. Ohashi K, Tanabe J, Watanabe R et al. The Japanese multicenter open randomized trial of ursodeoxycholic acid prophylaxis for hepatic veno-occlusive disease after stem cell transplantation. Am J Hematol 2000; 64: 32–38.

    Article  CAS  PubMed  Google Scholar 

  41. Wagner ML, Rosenberg HS, Fernbach DJ, Singleton EB . Typhilitis: a complication of leukemia in childhood. Am J Roentgenol Radium Ther Nucl Med 1970; 109: 341–350.

    Article  CAS  PubMed  Google Scholar 

  42. Shamberger RC, Weinstien HJ, Delorey MJ, Levey RH . The medical and surgical management of typhilitis in children with acute nonlymphocytic (myelogenous) leukemia. Cancer 1986; 57: 603–609.

    Article  CAS  PubMed  Google Scholar 

  43. Schuller I, Saha V, Lin L et al. Investigation and management of Clostridium difficile colonization in a paediatric oncology unit. Arch Dis Child 1995; 72: 219–222.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada

    C C Barker

  2. Department of Oncology, University of Calgary, Calgary, Alberta, Canada

    R A Anderson

  3. Community Health Sciences, University of Calgary, Calgary, Alberta, Canada

    R S Sauve

  4. Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada

    J D Butzner

Authors
  1. C C Barker
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R A Anderson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R S Sauve
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J D Butzner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C C Barker.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Barker, C., Anderson, R., Sauve, R. et al. GI complications in pediatric patients post-BMT. Bone Marrow Transplant 36, 51–58 (2005). https://doi.org/10.1038/sj.bmt.1705004

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705004

Keywords

This article is cited by

Search

Advanced search

Quick links